GSK Scores Midtrial Dismissal Of Paxil Birth Defect Suit

Law360, Philadelphia (April 4, 2016, 4:51 PM EDT) -- GlaxoSmithKline PLC on Monday scored a midtrial dismissal of claims that its antidepressant Paxil caused cardiac birth defects as a Pennsylvania state judge ruled that the plaintiffs hadn’t presented sufficient evidence to support their case.

GSK moved for a nonsuit on Monday after the plaintiffs rested the nearly two-week-old case alleging the company's Paxil caused cardiac birth defects. (Credit: AP) Judge Kenneth Powell in the Philadelphia County Court of Common Pleas granted GSK’s motion for compulsory nonsuit after ruling that physician Robert Kiehn had not testified...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.